Skip to main content
High RiskFDAfda-H-0320-2025UNDECLARED ALLERGEN

Crown Point Shelled Edamame, net wt. 22lbs. UPC 813973 01840 4. Product is packaged in carton box with poly liner. Distributed by Alpine ...

Category
Units Affected
1,046
Recall Date
June 13, 2025
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0320-2025.

Label declares Shelled Edamame but does not specify or declare soy.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0320-2025.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Alpine Food Distributing, Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0320-2025.

Alpine Food DIstributing, Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Alpine Food Distributing, Inc Recall FAQ

Alpine Food Distributing, Inc is the subject of a food safety report: Crown Point Shelled Edamame, net wt. 22lbs. UPC 813973 01840 4. Product is packaged in carton box with poly liner. Distributed by Alpine .... The notice was published on June 13, 2025 by the U.S. Food and Drug Administration (FDA). Approximately 1,046 units are potentially affected.